Every material Form 8-K Avantor filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.
Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
Approved by the Compensation and Human Resources Committee on October 30, 2026
Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% from a year earlier, and returned to year-over-year growth. GAAP diluted EPS was $0.30 versus a loss of $1.04 in the prior-year quarter, which included a $785.0 million goodwill impairment, and the company raised its fiscal 2026 organic revenue growth and free cash flow guidance. Adjusted EPS was flat at $0.22, and adjusted EBITDA fell to $256.9 million from $267.9 million.
Net sales $1,698.3 million, up 4.6% (5.2% organic); VWR Distribution & Services organic growth 5.8%
GAAP diluted EPS $0.30 vs. $(1.04) a year earlier; adjusted EPS $0.22, unchanged
Fiscal 2026 organic revenue growth guidance raised to +0.75% to +1.25% from -0.5% to +0.5%; free cash flow guidance raised to $525 million to $550 million
Free cash flow for the quarter was $156.2 million; total gross debt was $3,699.7 million at September 30, 2026
Avantor appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026, after he served as CFO of CONMED Corporation from January 2018 until March 2026. Steven Eck, who had been Interim CFO since June 24, 2026, will stop serving as interim CFO and remain Senior Vice President and Chief Accounting Officer, so the filing reports a change in the company's principal financial officer rather than a change in reported results.
Todd Garner's annual base salary is $700,000, with a target annual bonus of 80% of base salary and a one-time signing bonus of $150,000.
Garner's initial long-term equity grant has a target value of $1,500,000, split evenly between restricted stock units and stock options.
Garner will be eligible for a long-term incentive target annual grant of $3,000,000 in future years.
Steven Eck will continue as Senior Vice President and Chief Accounting Officer.
Avantor appointed Todd Garner as executive vice president and chief financial officer, effective September 21, 2026. Garner previously served as CFO of CONMED Corporation from January 2018 until March 2026, and Steven Eck will stop serving as interim CFO while remaining chief accounting officer.
Todd Garner, age 57, becomes principal financial officer effective September 21, 2026; he was CFO of CONMED Corporation from January 2018 to March 2026
Garner's employment letter, dated September 17, 2026, sets an annual base salary of $700,000 and a target annual bonus of 80% of base salary
Garner receives a one-time signing bonus of $150,000 and an initial long-term equity grant with a target amount of $1,500,000
Steven Eck ceases to be interim CFO but continues as senior vice president and chief accounting officer
Avantor reported second-quarter 2026 results on July 29, 2026. Net sales rose 0.5% to $1.69 billion, but organic sales fell 0.4%, and net income dropped to $38.1 million from $64.7 million a year earlier. The company raised parts of its fiscal 2026 guidance, including organic revenue growth and adjusted EPS, which signals improved expectations even though profit declined.
Net sales were $1,692.3 million, up 0.5%, with organic sales down 0.4%.
Net income was $38.1 million versus $64.7 million a year earlier; GAAP diluted EPS was $0.06 versus $0.09, and adjusted EPS was $0.21 versus $0.24.
Fiscal 2026 adjusted EPS guidance was raised to $0.80 to $0.83 from $0.77 to $0.83, and organic revenue growth guidance was narrowed to -0.5% to +0.5% from -2.5% to -0.5%.
The company repaid $112.1 million of debt in the quarter, and total gross debt was $3,715.4 million as of June 30, 2026.
Avantor Funding, a wholly owned subsidiary of Avantor, entered into Amendment No. 15 to its credit agreement on July 14, 2026, to obtain a €374,208,296.62 tranche of senior secured euro term loans. The new loans replace and refinance part of existing euro term loans that carried a higher spread, lowering the stated spread from 2.50% to 2.00% and maturing on October 9, 2032. The filing does not state a change to total debt, and a 1.00% prepayment premium applies if the loans are repriced within six months.
Incremental B-7 Euro Term Loans of €374,208,296.62 bear interest at EURIBOR plus 2.00%, down from 2.50% on the loans they replaced
Final maturity is October 9, 2032, the same date as the refinanced loans
A 1.00% prepayment premium applies to certain repricing transactions completed before the six-month anniversary of July 14, 2026
Loans are guaranteed and secured on a pari passu basis with the existing credit facilities
Avantor reported first-quarter 2026 results, with net sales of $1,581.4 million, flat from a year earlier, but a 4.1% organic decline after a positive currency effect of 4.1%. Net income fell to $43.3 million from $64.5 million, and diluted GAAP EPS dropped to $0.06 from $0.09, so shareholders saw lower profit on flat revenue. The company reaffirmed its fiscal 2026 guidance from February 11, 2026.
Net sales were $1,581.4 million, flat year over year; organic sales declined 4.1%.
Net income was $43.3 million versus $64.5 million; diluted GAAP EPS was $0.06 versus $0.09.
Adjusted EPS was $0.17 versus $0.23; adjusted EBITDA was $219.4 million versus $269.5 million.
Avantor reaffirmed fiscal 2026 guidance first given on February 11, 2026.
Avantor said Ludovic Brellier, formerly President of Cytiva's Hardware Solutions business at Danaher, will join as Executive Vice President, Bioscience & Medtech Products (BMP) and Chief Transformation Officer effective May 1, 2026. He will lead the BMP business and the Revival Management Office, which drives transformation initiatives across the enterprise. The filing also says current BMP segment head Benoit Gourdier is moving to a segment integration role and is expected to leave no later than December 31, 2026.
Ludovic Brellier starts May 1, 2026 as EVP, BMP and Chief Transformation Officer
Brellier will lead the Revival Management Office, overseeing enterprise transformation initiatives
Benoit Gourdier moves to a segment integration role and is expected to depart by December 31, 2026
The announcement was made in a press release dated April 23, 2026
Avantor said Executive Vice President and CFO R. Brent Jones will leave the company on or before June 24, 2026, to join a company outside the life sciences industry. Chief Accounting Officer Steve Eck will serve as interim CFO while the company searches for a permanent CFO, and the company reaffirmed its fiscal 2026 guidance.
Jones notified the company on March 26, 2026 of his resignation; his employment agreement requires 90 days' notice unless waived.
Eck, 50, has been Senior Vice President and Chief Accounting Officer since 2019 and will keep those roles while serving as interim CFO.
Eck will receive $45,000 per month as interim CFO and a one-time restricted stock unit award valued at $250,000 that vests over three years.
Avantor reaffirmed the fiscal 2026 financial guidance it gave on its fourth quarter 2025 earnings call on February 11, 2026.
Avantor reported fourth-quarter and full-year 2025 results on February 11, 2026, with sales down and a full-year GAAP net loss driven by a $785 million goodwill impairment. The company also said it is realigning its reporting into two segments starting in the first quarter of 2026, with recast historical data provided for investors.
Q4 2025 net sales were $1.66 billion, down 1.4% from a year earlier; Q4 GAAP diluted EPS was $0.08 versus $0.73 a year earlier, and adjusted EPS was $0.22 versus $0.27.
Full-year 2025 net sales were $6.55 billion, down 3.4%, with a net loss of $530 million versus net income of $712 million in 2024.
Full-year 2025 included an impairment charge of $785 million tied to the goodwill of the Distribution reporting unit; adjusted EPS was $0.90 versus $0.99 in 2024.
Two reportable segments, VWR Distribution & Services and Bioscience & Medtech Products, take effect in Q1 2026; the first 10-Q under the new structure is for the quarter ending March 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Avantor filing is on SEC EDGAR ↗. 8-K briefs of other companies →